Skip links

Pharmaceutical innovation incentives

Letter to the European Commission on the review of pharmaceutical innovation incentives

Commissioner Elżbieta BieńkowskaDirectorate-General for Internal Market, Industry, Entrepreneurship and SMEsBuilding BREY1049 BruxellesBelgique 18th December 2017 Dear Commissioner We write to voice our concern with the European Commission’s review of pharmaceutical incentives, in particular proposals under consideration to dilute intellectual property rights (IPRs). Such proposals should be